HackingHealthcareHealthcareCapture Stored DataData ExfiltratedCustomer Data InvolvedPIIIdentity (basic)LowContained

REVANCE THERAPEUTICS, INC.

bd_e49d1ca886a02735 · schema v1 · pii pii-v1

Severity

Low

Discovered

Apr 9, 2023

Filed

Jul 10, 2023

To disclose

13 weeks

Affected

Not disclosed

Linked

6 filings

Confidence

66%

Full breach record for REVANCE THERAPEUTICS, INC. →

Revance Therapeutics, Inc. disclosed that an unauthorized third party accessed and exfiltrated personal information from its systems between March 15, 2023, and April 10, 2023. The company discovered the incident on April 9, 2023. Affected data includes names and other personal information. Revance terminated the attacker's access, engaged cybersecurity specialists, notified law enforcement, and offered two years of identity monitoring through Kroll.

J jump to incidentP pin to compareR raw source

Incident timeline

undetected · 25 days

discovery → filing · 13 weeks / 92 days

Mar 15, 2023

Begins

Apr 9, 2023

Discovered

Jul 10, 2023

Filed

vs. sector median

+2 wks slower

This filing is one of 6 about the same incident.View merged incident

Linked disclosures

Why this link?

Regulatory filings (5) · sorted by filing gap

Montana State AGbd_5e56b9b5fb0d3cf22023-07-10Candidate
Indiana State AGbd_754fab104cb687832023-07-10Verified
Maine State AGbd_7f46058d018c83e52023-07-10Verified
Maine State AGbd_aea41b9feb5c83122023-07-10Verified

Show 1 more filing ↓

Massachusetts State AGbd_f7459893eddbdd492023-07-10Verified

Name: REVANCE THERAPEUTICS, INC.
norm: revance therapeutics

Name: REVANCE THERAPEUTICS, INC.
norm: revance therapeutics
Industry: Healthcarellm

Discovered: Apr 9, 2023
Breach occurred: Mar 15, 2023 – Apr 10, 2023
Undetected for: 25 daysoccurrence → discovery
Materiality determined: —
Notification sent: —
Affected individuals: Not disclosed
Data types: PIIIdentity (basic)
Attack vector: Unauthorized Access
MITRE ATT&CK: T1041 Exfiltration Over C2 ChannelT1078 Valid Accounts
Threat actor: External
Regulator citations: Notified law enforcement

During the incident: Terminated the third party’s access to the affected systems
Began an investigation
Engaged third-party cybersecurity specialists to investigate and resolve the incident
Notified law enforcement
Taken steps to enhance the security controls used to help protect your data
Arranged for complimentary two-year identity monitoring service through Kroll
Changes made: Taken steps to enhance the security controls used to help protect your data
Source: Quoted from the filing itself, not independently verified.

Time to disclose: 13 weeks(92 days from discovery to filing)
Compliance flags: — (clock not assessable for this source)

Status: No extraction artifact recorded for this disclosure.

Filing propagation · 6 filings · 5 states

View merged incident ↗

Montana State AGJul 10 · first

Indiana State AGJul 10 · first

Maine State AGJul 10 · first

Massachusetts State AGJul 10 · first

California State AGJul 10 · first · this page

Evidence ladder

Leak-site claim

Attacker assertion only. Establishes: claim date, group, alleged victim.

Press / market report

Unlocks: incident narrative, operational impact. Still no compliance clock.

State AG / regulator filingThis record

Unlocks: discovery date, data types, affected count, compliance clock.

SEC 8-K / victim statement

Unlocks: materiality, stated response, full audit trail. Ceiling removed.

Source URL: https://oag.ca.gov/ecrime/databreach/reports/sb24-569913
DisclosureLens links to the originating regulator URL — full filing bodies are not redistributed from public surfaces (§4.5).
Filed at: Jul 10, 2023
Raw hash: ad1abfd0d540f04378c156c9fb9d7200862c4b9ee5b2d18c708934655f78db62

Linked disclosures

Regulatory filings (5) · sorted by filing gap

Reporting entityREVANCE THERAPEUTICS, INC.

Victim entityREVANCE THERAPEUTICS, INC.

Incidentdiscovered Apr 9, 2023

Stated responseTerminated the third party’s access to the affected systems

Complianceclock not assessable

Extraction provenanceno artifact recorded

Source provenanceoag.ca.gov